Výsledky vyhledávání - "Dilfuza Kurbanbekova"

A prospective study of mifepristone and unlimited dosing of sublingual misoprostol for termination of second-trimester pregnancy in Uzbekistan and Ukraine

Autor: Dilfuza Kurbanbekova, Beverly Winikoff, Tamar Tsereteli, Galyna Maystruk, Ingrida Platais

Publikováno v: BMJ Sexual & Reproductive Health. 45:177-182

IntroductionWe aimed to assess the feasibility and acceptability of a second-trimester medical abortion regimen using mifepristone and sublingual misoprostol with no maximum number of misoprostol doses in Uzbekistan and Ukraine.MethodsThis prospectiv

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::42b3b35315438ede26a046617d0bc101
https://doi.org/10.1136/bmjsrh-2018-200167

Zobrazit plný text záznamu

Acceptability and feasibility of phone follow-up with a semiquantitative urine pregnancy test after medical abortion in Moldova and Uzbekistan

Autor: Beverly Winikoff, Ingrida Platais, Dilfuza Kurbanbekova, Tamar Tsereteli, Rodica Comendant

Publikováno v: Contraception. 91:178-183

Objective To evaluate the feasibility and acceptability of phone follow-up with a home semiquantitative pregnancy test and standardized checklist, and compare the alternative method of follow-up with in-clinic follow-up after medical abortion. Study

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::5751389811d4afe6123d9a2f83b461f3
https://doi.org/10.1016/j.contraception.2014.11.004

Zobrazit plný text záznamu

Acceptability and feasibility of the use of 400 μg of sublingual misoprostol after mifepristone for medical abortion up to 63 days since the last menstrual period: Evidence from Uzbekistan

Autor: Feruza Kasimova, Beverly Winikoff, Sheila Raghavan, Dilmurod Yusupov, Dilfuza Kurbanbekova, Dilbar Jymagylova, Asamidin Kamilov, Tamar Tsereteli

Publikováno v: The European Journal of Contraception & Reproductive Health Care. 18:104-111

To examine the efficacy, acceptability and feasibility of early medical abortion, with the option of home administration of misoprostol, in Uzbekistan.A total of 450 women were enrolled at national, municipal and private facilities in Tashkent, Uzbek

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::f83c9e784c682b58d46bc97e9817b9e2
https://doi.org/10.3109/13625187.2013.763225

Zobrazit plný text záznamu

Plný text ve formátu HTML

A randomized controlled trial comparing repeat doses of 400 mcg sublingual to buccal misoprostol after mifepristone for termination of pregnancy 13–21 weeks

Autor: R. Abrahamyan, Tamar Tsereteli, Erica Chong, Dilfuza Kurbanbekova, Ingrida Platais, Beverly Winikoff, Yi Ling Tan, C. Murtagh, Hillary Bracken, Selma Hajri, Tara Shochet, Rasha Dabash, E. Sfar, Chanda Karki, D. Sadikova, J. Bajracharya

Publikováno v: Contraception. 95:515

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::cd50cd4ece5038fa0cdd6abd118b67e2
https://doi.org/10.1016/j.contraception.2017.02.004

Zobrazit plný text záznamu

Vyhledávací nástroje:

Upřesnit hledání